[Occult hepatitis B reactivation in a patient with homozygous sickle cell disease: clinical case and literature review]
- PMID: 29515745
- PMCID: PMC5837157
- DOI: 10.11604/pamj.2017.28.127.13640
[Occult hepatitis B reactivation in a patient with homozygous sickle cell disease: clinical case and literature review]
Abstract
Occult Hepatitis B corresponds to the presence of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) in serum and/or in liver of a patient despite HBsAg negativity. Clinically, it is usually asymptomatic. Its reactivation is rare and commonly occurs in immunosuppressed individuals. We report the case of a 21-year old patient from Senegal, with homozygous sickle cell disease, presenting with cholestatic jaundice. Laboratory tests showed reactivation of occult Hepatitis B. This study emphasizes the need to systematically investigate the presence of occult Hepatitis B in patients with sickle cell disease suffering from acute liver disease.
L'hépatite B occulte correspond à la présence de l'ADN du virus de l'hépatite B dans le sérum et/ou dans le foie d'un patient malgré la négativité de l'AgHBs. C'est une forme clinique habituellement asymptomatique. Sa réactivation est rare et survient en général chez le sujet immunodéprimé. Nous rapportons un cas d'un patient sénégalais de 21 ans, drépanocytaire homozygote, qui présentait un ictère de type cholestatique chez qui l'exploration biologique concluait a une réactivation d'une hépatite B occulte. Cette observation souligne la nécessité de rechercher systématiquement une réactivation d'une hépatite B occulte devant toute hépatopathie aigue chez le drépanocytaire.
Keywords: Occult Hepatitis B; homozygous sickle cell disease; reactivation.
Figures
Similar articles
-
Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.Transpl Infect Dis. 2013 Jun;15(3):300-5. doi: 10.1111/tid.12065. Epub 2013 Mar 8. Transpl Infect Dis. 2013. PMID: 23473005
-
Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.World J Gastroenterol. 2013 Oct 7;19(37):6214-20. doi: 10.3748/wjg.v19.i37.6214. World J Gastroenterol. 2013. PMID: 24115819 Free PMC article.
-
Management of occult hepatitis B virus infection: an update for the clinician.World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12.1563. World J Gastroenterol. 2011. PMID: 21472122 Free PMC article. Review.
-
Occult hepatitis B virus infection: a complex entity with relevant clinical implications.World J Gastroenterol. 2011 Mar 28;17(12):1529-30. doi: 10.3748/wjg.v17.i12.1529. World J Gastroenterol. 2011. PMID: 21472115 Free PMC article.
-
Diagnostic strategy for occult hepatitis B virus infection.World J Gastroenterol. 2011 Mar 28;17(12):1553-7. doi: 10.3748/wjg.v17.i12.1553. World J Gastroenterol. 2011. PMID: 21472120 Free PMC article. Review.
Cited by
-
Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review.World J Hepatol. 2024 May 27;16(5):843-859. doi: 10.4254/wjh.v16.i5.843. World J Hepatol. 2024. PMID: 38818293 Free PMC article.
References
-
- World Health Organization . Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. WHO; 2015. Mar, - PubMed
-
- Lo G, Diawara PS, Diouf NN, Faye B, Seck MC, Sow K, Sarré SM, Ndiaye HD, Touré Kane NC, Mboup S. Prévalence de l'antigène de surface du virus de l'héaptite B (Ag HBs) chez les femmes enceintes au laboratoire de l'hôpital militaire d'Ouakam (HMO), Dakar. Méd Afr Noire. 2012;59(5):241–244.
-
- Vallet-Pichard A, Pol S. L'hépatite B occulte. Virologie. 2008;12(2):87–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical